Research shows why ketamine is an effective antidepressant but memantine is not

May 27, 2014 by Marcia Malory report
One 10 ml vial of 1000 mg ketamine. Credit: Psychonaught/Wikipedia

(Medical Xpress)—Ketamine is a fast-acting antidepressant. However, it can create symptoms that mimic psychosis. Therefore, doctors don't give it to depressed patients. Memantine, a similar drug, does not have psychotomimetic effects, but it also does not appear to alleviate depression. Lisa M. Monteggia of the University of Texas Southwestern Medical Center and her colleagues have determined that these drugs have different effects on neurotransmitter pathways. In particular, ketamine promotes the expression of neurotrophic factors but memantine doesn't. The research appears in the Proceedings of the National Academy of Sciences.

Traditional antidepressants target the monoamine system. Patients who take them require several weeks of treatment before they begin to feel an effect. In some cases, for example, if the patient is suicidal, waiting this long can be dangerous. A fast-acting antidepressant would be a preferable treatment.

Ketamine is such a fast-acting drug. Patients have reported experiencing its antidepressant effects within 30 minutes to a few hours after a single intravenous dose. Unlike traditional antidepressants, does not affect the monoamine system. It is an NMDA receptor antagonist. Unfortunately, it can cause ; therefore, doctors do not prescribe it for treatment of depression.

As an alternative to ketamine, pharmacologists have considered using the drug memantine, another NMDA receptor antagonist. Memantine, used to treat patients with Alzheimer's disease, does not cause psychotic symptoms and therefore would be safer to use. Clinical studies, however, have shown that it does not behave as an antidepressant. Until now, researchers haven't understood why.

To understand the differences between these two drugs, Monteggia's team first tested their antidepressant properties on mice. Tests confirmed previous observations that ketamine acts as an antidepressant but memantine does not.

The team then used electrophysiology to examine the effect of ketamine and memantine on cultured mouse hippocampal neurons. They found key functional differences in how the drugs suppress NMDA receptor function at rest and how they inhibit the eukaryotic elongation factor 2 kinase (eEF2K) signaling pathway.

When the extracellular recording solution did not contain magnesium, both ketamine and memantine antagonized NMDA receptors. However, with the addition of magnesium, ketamine blocked NMDA receptors, but did not. In addition, ketamine inhibited the phosphorylation of eeF2 and augmented expression of brain derived neurotrophic factor (BDNF). Memantine did not produce these effects. Augmentation of BNDF makes ketamine an effective antidepressant.

These findings could help scientists develop new, fast-acting antidepressants with fewer side effects.

Explore further: Intranasal ketamine confers rapid antidepressant effect in depression

More information: Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses, PNAS, 2014.

Related Stories

Intranasal ketamine confers rapid antidepressant effect in depression

April 8, 2014
A research team from the Icahn School of Medicine at Mount Sinai published the first controlled evidence showing that an intranasal ketamine spray conferred an unusually rapid antidepressant effect –within 24 hours—and ...

Would an 'anti-ketamine' also treat depression?

November 18, 2013
Thirteen years ago, an article in this journal first reported that the anesthetic medication, ketamine, showed evidence of producing rapid antidepressant effects in depressed patients who had not responded to prior treatments. ...

Ketamine helps see how the brain works in clinical depression

June 16, 2011
(Medical Xpress) -- In a new study published in Nature, Lisa Monteggia from the University of Texas Southwestern Medical Center looks at how the drug ketamine, typically used as an anesthetic or a popular recreational drug ...

Ketamine acts as antidepressant by boosting serotonin

January 7, 2014
Ketamine is a potent anesthetic employed in human and veterinary medicine, and sometimes used illegally as a recreational drug. The drug is also a promising candidate for the fast treatment of depression in patients who do ...

Ketamine improved bipolar depression within minutes

May 30, 2012
Bipolar disorder is a serious and debilitating condition where individuals experience severe swings in mood between mania and depression. The episodes of low or elevated mood can last days or months, and the risk of suicide ...

Experimental agent briefly eases depression rapidly in test: Works in brain like ketamine, with fewer side effects

December 11, 2012
(Medical Xpress)—A drug that works through the same brain mechanism as the fast-acting antidepressant ketamine briefly improved treatment-resistant patients' depression symptoms in minutes, with minimal untoward side effects, ...

Recommended for you

Before assigning responsibility, our minds simulate alternative outcomes, study shows

October 17, 2017
How do people assign a cause to events they witness? Some philosophers have suggested that people determine responsibility for a particular outcome by imagining what would have happened if a suspected cause had not intervened.

For older adults, volunteering could improve brain function

October 17, 2017
Older adults worried about losing their cognitive functions could consider volunteering as a potential boost, according to a University of Missouri researcher. While volunteering and its associations with physical health ...

Magic mushrooms may 'reset' the brains of depressed patients

October 13, 2017
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.

Living near a forest keeps your amygdala healthier

October 13, 2017
A study conducted at the Max Planck Institute for Human Development has investigated the relationship between the availability of nature near city dwellers' homes and their brain health. Its findings are relevant for urban ...

Scientists researching drugs that could improve brain function in people with schizophrenia

October 12, 2017
Virginia Commonwealth University researchers are testing if drugs known as HDAC inhibitors improve cognition in patients with schizophrenia who have been treated with the antipsychotic drug clozapine.

Researchers find a fine timeline between delusion and reality

October 12, 2017
The line between reality and delusion may be just a matter of time, a new Yale study suggests.


Adjust slider to filter visible comments by rank

Display comments: newest first

5 / 5 (4) May 27, 2014
To the contrary, doctors DO prescribe ketamine for the treatment of depression. I suffered from extreme depression for over 30 years, and volunteered for a clinical trial at the National Institutes of Health a couple years ago, where ketamine relieved all of my symptoms within hours. Since then, I have received regular ketamine treatment and am able to live a normal life for the first time in decades. The number of doctors offering this treatment is growing rapidly. The Ketamine Advocacy Network maintains a directory of these doctors at
3 / 5 (4) May 27, 2014
Thanks for the link, ibim.
3.5 / 5 (2) May 27, 2014
Would opiates also be considered anti-depressants?
5 / 5 (2) May 28, 2014
Ketamine has worked wonders with me too.

Anyone suffering from schizophrenia or confusion, and negative effects from Ket should try Sarcosine.

Sarcosine is an NMDA Agonist (opposite of Ket), but has much the same effect, but only if taken every day for at least a few weeks. Both Ketamine and Sarcosine have worked wonderfully for me, and I am now on the latter due it it being legal, safe, and gentler on my mind. But nothing can beat Ketamines instant effects, and life saving potential.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.